Navigation Links
CORRECTED - Akorn, Inc. Announces Date Change for Third Quarter 2010 Earnings Release and Conference Call
Date:10/13/2010

LAKE FOREST, Ill., Oct. 13 /PRNewswire-FirstCall/ -- Akorn, Inc. (Nasdaq: AKRX) will host a conference call on Tuesday, November 2, 2010, to discuss third quarter 2010 results followed by a Q&A session.  The company will release earnings the same day before the market opens. Subject:

Akorn Third Quarter 2010 Conference CallDate/Time:

Tuesday, November 2, 2010, at 10:00 a.m. Eastern TimeDomestic Callers:

(888) 215-6895International Callers:

(913) 312-0860Confirmation Code:

2146785URL For Webcast:

http://www.videonewswire.com/event.asp?id=73076A live broadcast of Akorn's conference call will also be available online at www.akorn.com under the investor relations tab on November 2, 2010, beginning at 10:00 a.m. (Eastern Time).  The online replay will follow immediately and will be available for 30 days.  Please note, later in the afternoon on November 2nd Raj Rai and Tim Dick will be presenting at the Oppenheimer 21st Annual Healthcare Conference in New York at the Waldorf Astoria.

About Akorn, Inc.Akorn, Inc. is a niche pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals.  Akorn has manufacturing facilities located in Decatur, Illinois and Somerset, New Jersey where the Company manufactures ophthalmic and injectable pharmaceuticals.  Additional information is available on the Company's website at www.akorn.com.


'/>"/>

SOURCE Akorn, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Akorn, Inc. Announces Third Quarter 2010 Earnings Release and Conference Call Information
2. Prime Therapeutics Announces URAC Accreditation
3. Regeneron Announces Exercise of Over-Allotment Option and Closing of Underwritten Offering of Common Stock
4. Cellectis bioresearch Announces Establishment of Subsidiary in the US
5. BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX® for Treatment of Peyronies Disease
6. Titan Pharmaceuticals Announces Journal of the American Medical Association Publication of Phase 3 Probuphine™ Data
7. Misonix Announces Change in Distribution of SonaStar® Surgical Aspiration System in the U.S.
8. Express Scripts Announces Third Quarter 2010 Earnings and 2011 Earnings Guidance Conference Call
9. Archimedes Pharma Announces Publication of Long-Term Safety and Tolerability Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in the Journal of Opioid Management
10. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
11. Adeona Announces Five Scientific Publications on Role of Copper Toxicity and Zinc Deficiency in Alzheimers Disease and Cognitive Decline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in ... ways they remain in the eye of the beholder, according to experts who offered ... The American Journal of Managed Care. For the full issue, click here . ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):